These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 29946821)

  • 21. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenic factors are increased in circulating granulocytes and CD34
    Subotički T; Mitrović Ajtić O; Beleslin-Čokić BB; Nienhold R; Diklić M; Djikić D; Leković D; Bulat T; Marković D; Gotić M; Noguchi CT; Schechter AN; Skoda RC; Čokić VP
    Mol Carcinog; 2017 Feb; 56(2):567-579. PubMed ID: 27341002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
    Čokić VP; Mitrović-Ajtić O; Beleslin-Čokić BB; Marković D; Buač M; Diklić M; Kraguljac-Kurtović N; Damjanović S; Milenković P; Gotić M; Raj PK
    Mediators Inflamm; 2015; 2015():453020. PubMed ID: 26491227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
    Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis.
    Cerezo LA; Remáková M; Tomčik M; Gay S; Neidhart M; Lukanidin E; Pavelka K; Grigorian M; Vencovský J; Šenolt L
    Rheumatology (Oxford); 2014 Aug; 53(8):1520-6. PubMed ID: 24643522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
    Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
    Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.
    Özbay Kurt FG; Cicortas BA; Balzasch BM; De la Torre C; Ast V; Tavukcuoglu E; Ak C; Wohlfeil SA; Cerwenka A; Utikal J; Umansky V
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39266214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
    Reeb AN; Li W; Sewell W; Marlow LA; Tun HW; Smallridge RC; Copland JA; Spradling K; Chernock R; Lin RY
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E232-42. PubMed ID: 25423568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100A9 gene silencing inhibits the release of pro-inflammatory cytokines by blocking the IL-17 signalling pathway in mice with acute pancreatitis.
    Wu DM; Wang S; Shen M; Wang YJ; Zhang B; Wu ZQ; Lu J; Zheng YL
    J Cell Mol Med; 2018 Apr; 22(4):2378-2389. PubMed ID: 29441717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.
    Liang F; Liang X; Pan L; Jin Q; Deng J; Hong M; Wei W; Hao Z; Ren H; Wang H; Chen X
    Clin Exp Med; 2024 May; 24(1):106. PubMed ID: 38771542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis.
    Ryu MJ; Liu Y; Zhong X; Du J; Peterson N; Kong G; Li H; Wang J; Salamat S; Chang Q; Zhang J
    J Biol Chem; 2012 Jun; 287(27):22948-58. PubMed ID: 22577135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
    Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A8/A9: From basic science to clinical application.
    Pruenster M; Vogl T; Roth J; Sperandio M
    Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways.
    Kang JH; Hwang SM; Chung IY
    Immunology; 2015 Jan; 144(1):79-90. PubMed ID: 24975020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms.
    Angona A; Alvarez-Larrán A; Bellosillo B; Longarón R; Camacho L; Fernández-Rodríguez MC; Pairet S; Besses C
    Leuk Res; 2016 Sep; 48():11-5. PubMed ID: 27427771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.